Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5359414 | 0.98 | KEAP1 (0.45) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| Bromide SCHEMBL25379769 | 0.98 | KEAP1 (0.45) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| Bromide SCHEMBL12497329 | 0.98 | KEAP1 (0.45) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| Hydrochloric Acid SCHEMBL28832277 | 0.98 | KEAP1 (0.45) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| Bromide SCHEMBL28027686 | 0.96 | KEAP1 (0.43) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| SCHEMBL838217 | 0.87 | HDAC3 (0.50) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| SCHEMBL7524058 | 0.86 | GAA (0.41) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| Bromide SCHEMBL8104984 | 0.85 | HDAC3 (0.48) | KEAP1NR4A2FFAR1HDAC3HDAC4 | |
| SCHEMBL1838985 | 0.85 | HDAC3 (0.50) | KEAP1NR4A2HDAC3HDAC4HDAC1 | |
| SCHEMBL15132444 | 0.84 | HDAC3 (0.53) | KEAP1HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594713-A | Small molecule probe for extracting and purifying mitochondria and preparation method and application thereof | 西北工业大学（CN） | 2023-01-13 | — | — | CN | claimed |
| WO-2026100367-A1 | RESIST MATERIAL AND PATTERN FORMATION METHOD | 東京応化工業株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2025094826-A1 | HETEROPOLYOXOMETALATE HAVING MODIFIED LACUNARY SITE, OR MIXTURE THEREOF | 東京応化工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2025094854-A1 | METHOD FOR PRODUCING POLYACID SALTS OR MIXTURES THEREOF, AND METHOD FOR REMOVING IMPURITIES | 東京応化工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| CN-119948603-A | Dry etching residue removing liquid | 株式会社德山 | 2025-05-06 | — | — | CN | disclosed |
| CN-119601113-A | Method for comprehensively identifying and comprehensively evaluating risk of phosphorus-containing organic compounds in environment | 中国科学院生态环境研究中心 | 2025-03-11 | — | — | CN | disclosed |
| CN-118974895-A | Filter lubricant containing onium ion | 株式会社德山 | 2024-11-15 | — | — | CN | disclosed |
| CN-118613472-A | Nicotinamide ester and nicotinamide riboside-based compounds and derivatives thereof | 新前沿生物公司 | 2024-09-06 | — | — | CN | disclosed |
| US-20240216516-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | TIGER BIOTHERAPEUTICS INC. | 2024-07-04 | — | — | US | disclosed |
| WO-2024143473-A1 | DECOMPOSITION INHIBITOR FOR TRANSITION METAL OXIDANTS | 株式会社トクヤマ | 2024-07-04 | — | — | WO | disclosed |
| US-4766128-A | Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-08-23 | — | — | US | disclosed |
| EP-0056358-B1 | NOVEL (2-HALOERGOLINYL)-N'-N'-DIETHYLUREA DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF AS MEDICINAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-04-22 | — | — | EP | disclosed |
| US-4639464-A | Antihypertensive substituted imidazole derivatives | FARMOS GROUP, LTD. (FI) | 1987-01-27 | — | — | US | disclosed |
| EP-0201071-A2 | 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1986-11-12 | — | — | EP | disclosed |
| EP-0072615-B1 | SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR PREPARATION AND USE | Farmos Group Ltd. (FI) | 1985-12-27 | — | — | EP | disclosed |
| US-4544664-A | Antihypertensive substituted imidazole derivatives | FARMOS GROUP, LTD. (FI) | 1985-10-01 | — | — | US | disclosed |
| US-4492797-A | DIURETICS | HOFFMANN-LA ROCHE INC. (US) | 1985-01-08 | — | — | US | disclosed |
| EP-0072615-A1 | Substituted imidazole derivatives and their preparation and use | Farmos Group Ltd. (FI) | 1983-02-23 | — | — | EP | disclosed |
| EP-0056358-A1 | Novel (2-haloergolinyl)-N'-N'-diethylurea derivatives, process for the preparation thereof, and use thereof as medicinal agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-07-21 | — | — | EP | disclosed |
| US-4255436-A | 2-Oxo-3 thiazoline-oximes as pesticides | HOFFMANN-LA ROCHE INC. (US) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216516-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | KRAS, VHL, HRAS | KEAP1 46/4885NR4A2 3520/4885FFAR1 3201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.